Skip to content

Based on my analysis of the GO-CAM model and the information provided, I'll now conduct a comprehensive review of GO-CAM model 653b0ce600001283:

Review of GO-CAM Model: gomodel:653b0ce600001283

Model Overview

Title: KSHV-ORF57 inhibition of host P-body formation (Human-HHV8)
Taxon: Human (NCBITaxon:9606)
Status: Production
URL: https://bioregistry.io/go.model:653b0ce600001283

Model Content

This model represents the interaction between a viral protein from Kaposi's sarcoma-associated herpesvirus (KSHV) and human host factors involved in P-body formation. The model focuses on how KSHV ORF57 protein inhibits P-body formation by interacting with host proteins TNRC6A (GW182) and AGO2.

Key Entities in the Model

Proteins

  1. TNRC6A (Q8NDV7): Human protein-macromolecule adaptor protein (GW182)
  2. AGO2 (Q9UKV8): Human protein with RNA endonuclease activity
  3. ORF57 (Q2HR75): KSHV viral protein with protein sequestering activity

Processes/Activities

  1. P-body assembly (GO:0033962)
  2. Positive regulation of viral life cycle (GO:1903902)

Model Accuracy Assessment

Scientific Content Accuracy

The model accurately represents the interaction between KSHV ORF57 and host factors based on the literature evidence. The PMID:31400113 paper clearly demonstrates that KSHV ORF57 inhibits P-body formation by interacting with Ago2 and GW182/TNRC6A. This is correctly represented in the model.

Model Structure Assessment

Causal Flow

The causal flow follows logically from the viral protein ORF57 to its effects on host proteins: - ORF57 sequestering activity → interacts with TNRC6A → affects P-body assembly - TNRC6A adaptor activity → regulates AGO2 → affects RNA endonuclease activity

The model correctly uses RO:0012010 (equivalent to 'directly negatively regulates') to show ORF57's effect on TNRC6A, and RO:0002629 ('directly positively regulates') to show TNRC6A's effect on AGO2.

Evidence Support

The model is well supported by published evidence: - PMID:31400113 is used for the main interactions - PMID:22681889 provides evidence for TNRC6A-AGO2 interactions - PMID:18178619 supports AGO2 RNA endonuclease activity

Cellular Locations

The model correctly specifies cellular locations: - ORF57 in host cell cytoplasm (GO:0030430) - TNRC6A and AGO2 in P-body (GO:0000932)

Issues Identified

  1. Redundant Causal Association:
  2. There are duplicate causal associations between TNRC6A and AGO2
  3. The activity "gomodel:653b0ce600001283/653b0ce600001405" (TNRC6A) has two identical causal associations with "gomodel:653b0ce600001283/653b0ce600001398" (AGO2) using the same predicate (RO:0002629)

  4. One of these should be removed to eliminate redundancy

  5. Molecular Function Assignment:

  6. The model correctly assigns protein sequestering activity (GO:0140311) to ORF57, which aligns with its biological role of sequestering host factors

  7. Model Completeness:

  8. The model adequately represents the key aspects of the biological process described in the literature
  9. However, it could potentially be expanded to include downstream effects of P-body disruption on viral replication

Recommendations for Improvement

  1. Remove Redundant Causal Association:

  2. Remove one of the duplicate causal associations between TNRC6A and AGO2

  3. Consider Additional Connections:

  4. The model could potentially be expanded to include the effect of P-body disruption on viral mRNA stability or translation, which would provide a more complete picture of how this mechanism benefits viral replication

  5. Add Further Context:

  6. Consider adding a comment or annotation explaining the biological significance of this mechanism for viral life cycle

Conclusion

The GO-CAM model "653b0ce600001283" is scientifically accurate and largely follows GO-CAM best practices. It correctly represents the mechanism by which KSHV ORF57 inhibits host P-body formation through interaction with TNRC6A and AGO2. The model shows the role of a viral protein (ORF57) in disrupting a host cellular process (P-body assembly) through protein sequestering activity.

The only significant issue is the redundant causal association between TNRC6A and AGO2, which should be removed to maintain model clarity and accuracy. Otherwise, the model is well-constructed, with appropriate molecular functions, cellular locations, and causal relationships supported by relevant evidence from the literature.